Aminorex

This classification denotes an anorexiant with the molecular formula C9H10N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 2SH16612I9, chemically known as 4,5-dihydro-5-phenyl-2-oxazolamine but more generally known as aminorex, which bears US NIH Compound Identifier 16630. Aminorex most often comes in base and fumarate forms. European Medicines Agency schedules Aminorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05448MIG. The term AMINOREX is an International Non-Proprietary Name. AMINOREX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule aminorex under HS 29349100 and SITC 51579. As of Q4 2014, AMINOREX remains US FDA's Preferred Term for this commodity. Aminorex bears US NLM identifiers UMLS ID C0002589 and NCI Concept Code C72180. SMILES: O1C(CN=C1N)C1CCCCC1.